[1] Alberio T, Fasano M. Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies [J]. J Biotechnol, 2010, 156(4): 325-337.[2] Spillantini M G, Crowther R A, Jakes R, et al. alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies [J]. Proc Natl Acad Sci U S A, 1998, 95(11):6469-6473.[3] Spillantini M G, Schmidt M L, Lee V M, et al. Alpha-synuclein in Lewy bodies [J]. Nature, 1997, 388(6645): 839-840.[4] Baba M, Nakajo S, Tu P H,et al. Aggregation of alphasynuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies [J]. Am J Pathol, 1998, 152(4): 879-884.[5] Ferrer I, Martinez A, Blanco R, et al. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson's disease [J]. J Neural Transm, 2011, 118(5): 821-839.[6] Sulzer D, Surmeier D J. Neuronal vulnerability, pathogenesis, and Parkinson's disease [J]. Mov Disord, 2013, 28(6): 41-50.[7] Kalia L V, Kalia S K, McLean P J, et al. α-Synuclein oligomers and clinical implications for Parkinson disease [J]. Ann Neurol, 2013, 73(2): 155-169.[8] Danzer K M, McLean P J. Drug targets from genetics: alpha-synuclein [J]. CNS Neurol Disord Drug Targets, 2011, 10(6): 712-723.[9] Maroteaux L, Campanelli J T, Scheller R H. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal [J]. Neurosci,1988, 8(8):2804-2815.[10] Polymeropoulos M H, Higgins J J, Golbe L I, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23 [J]. Science, 1996, 274(5290):1197-1199.[11] Kruger R, Muller T, Riess O. Involvement of alpha-synuclein in Parkinson's disease and other neurodegenerative disorders [J]. Neural Transm,2000, 107 (1):31-40.[12] Alim M A, Ma Q L, Takeda K, et al. Demonstration of a role for alpha-synuclein as a functional microtubule-associated protein [J]. J Alzheimers Dis, 2004, 6(4): 435-442.[13] Guangwei L, Wang P, Xin L, et al. Alpha-synuclein promotes early neurite outgrowth in cultured primary neurons [J]. Neural Transm, 2013, 120(9): 1331-1343.[14] 王鹏,许洁,李昕,等. 突变型alpha-突触核蛋白对大鼠原代培养神经元突起生长作用研究 [J]. 首都医科大学学报,2012,33(5), 629-633.[15] 李雁,殷娟娟,李昕,等. α-突触核蛋白寡聚体对多巴胺能神经细胞线粒体膜电位的影响[J]. 中国现代神经疾病杂志,2008 (8): 26-31.[16] Kohn J Y, Choi D W. Quantitative determination of glutamatemediated cortical neuronal injury in cell by lactate dehydrogenase efflux assay [J]. J Neurosci Methods, 1987, 20(1): 83-90.[17] Alim M A, Hossain M S, Arima K, et al. Tubulin seeds alpha-synuclein fibril formation [J]. J Biol Chem, 2002, 277(3): 2112-2117.[18] 刘光伟, 王鹏,李尧华,等. α-突触核蛋白促进大鼠原代培养神经元突起生长 [J]. 首都医科大学学报,2009, 30(5): 607-610.[19] 尹娜, 陈予东,李昕,等. 帕金森病患者血浆增强α-突触核蛋白寡聚体形成 [J]. 首都医科大学学报,2013,34(6): 840-843.[20] 李瑛, 刘光伟,李昕,等. α-突触核蛋白促进过氧化氢诱导的多巴胺能神经细胞凋亡 [J]. 首都医科大学学报, 2011,32(6):771-776.[21] Sung J Y, Kim J, Paik S R. Induction of neuronal cell death by Rab5A-dependent endocytosis of alpha-synuclein [J]. Biol Chem,2001, 276(29):27441-27448.[22] Chen L, Jin J, Davis J, et al. Oligomeric alpha-synuclein inhibits tubulin polymerization [J]. Biochem Biophys ResCommun, 2007, 356(3): 548-553. |